Overview
Variably protease-sensitive prionopathy (VPSPr) is an extremely rare brain disease belonging to the family of prion diseases, also known as transmissible spongiform encephalopathies. Prion diseases are caused by the abnormal folding of a normal brain protein called the prion protein (PrP). In VPSPr, the misfolded prion protein has a unique feature: it is only partially broken down by enzymes called proteases, which is different from other prion diseases like Creutzfeldt-Jakob disease (CJD). This characteristic gives the disease its name. VPSPr affects the brain by causing progressive damage to nerve cells, leading to tiny sponge-like holes in brain tissue. Symptoms typically develop in middle to older age and may include problems with thinking and memory (dementia), difficulty speaking (aphasia), trouble with coordination and walking (ataxia), personality and behavioral changes, and psychiatric symptoms such as depression or anxiety. The disease progresses over months to years, and symptoms gradually worsen over time. Currently, there is no cure or disease-modifying treatment for VPSPr. Care focuses on managing symptoms and providing comfort and support. Because VPSPr is so rare and was only first described in 2008, research is still ongoing to better understand the disease. It is sometimes confused with other forms of prion disease, and diagnosis can be challenging, often requiring specialized testing and sometimes only confirmed after death through brain tissue examination.
Key symptoms:
Progressive memory loss and confusion (dementia)Difficulty speaking or finding wordsProblems with balance and coordinationUnsteady walkingPersonality and behavioral changesPsychiatric symptoms such as depression or anxietyInvoluntary jerking movements (myoclonus)Difficulty swallowingWeight lossSleep disturbancesSlowed thinking and processingMuscle stiffness or rigidityProgressive loss of independence
Sporadic
Usually appears on its own, not inherited from a parent
Late onset
Begins later in life, typically after age 50
Treatments
No FDA-approved treatments are currently listed for Variably protease-sensitive prionopathy.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Variably protease-sensitive prionopathy at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Variably protease-sensitive prionopathy.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Variably protease-sensitive prionopathy.
Community
No community posts yet. Be the first to share your experience with Variably protease-sensitive prionopathy.
Start the conversation →Latest news about Variably protease-sensitive prionopathy
No recent news articles for Variably protease-sensitive prionopathy.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.How certain is the diagnosis of VPSPr, and what tests were used to reach this conclusion?,What is the expected course of the disease in my case, and how quickly might symptoms progress?,What treatments or therapies are available to help manage my symptoms?,Are there any clinical trials or research studies I might be eligible for?,Should my family members undergo any genetic testing?,When should we begin planning for advanced care needs and palliative care?,What support services are available for me and my family, including counseling and caregiver support?
Common questions about Variably protease-sensitive prionopathy
What is Variably protease-sensitive prionopathy?
Variably protease-sensitive prionopathy (VPSPr) is an extremely rare brain disease belonging to the family of prion diseases, also known as transmissible spongiform encephalopathies. Prion diseases are caused by the abnormal folding of a normal brain protein called the prion protein (PrP). In VPSPr, the misfolded prion protein has a unique feature: it is only partially broken down by enzymes called proteases, which is different from other prion diseases like Creutzfeldt-Jakob disease (CJD). This characteristic gives the disease its name. VPSPr affects the brain by causing progressive damage t
How is Variably protease-sensitive prionopathy inherited?
Variably protease-sensitive prionopathy follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Variably protease-sensitive prionopathy typically begin?
Typical onset of Variably protease-sensitive prionopathy is late onset. Age of onset can vary across affected individuals.